NVO logo

Novo Nordisk A/S (NVO) Cost Of Goods Sold

Annual Cost Of Goods Sold

$5.19 B
+$1.16 B+28.76%

31 December 2023

1-Year Change

+28.76%
NVO annual cost of goods sold is up +28.76% year-on-year

3-Year Change

+61.9%
NVO annual cost of goods sold is up +61.9% over the past 3 years

All-time High

$5.19 B
NVO annual cost of goods sold is currently at an all-time high

Sector Rank

93.23%
NVO annual cost of goods sold is higher than 93.23% of companies in Healthcare sector
Annual Revenue$33.72 B
NVO annual revenue is $33.72 billion
Annual Gross Profit$28.53 B
NVO annual gross profit is $28.53 billion
Annual Operating Profit$14.89 B
NVO annual operaing income is $14.89 billion
Annual Net Income$12.15 B
NVO annual net profit is $12.15 billion

NVO Cost Of Goods Sold Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Cost Of Goods Sold

$1.67 B
+$183.49 M+12.37%

30 September 2024

1-Year Change

+17.49%
NVO quarterly cost of goods sold is up +17.49% year-on-year

3-Year Change

+73.48%
NVO quarterly cost of goods sold is up +73.48% over the past 3 years

All-time High

$1.67 B
NVO quarterly cost of goods sold is currently at an all-time high

Sector Rank

93.65%
NVO quarterly cost of goods sold is higher than 93.65% of companies in Healthcare sector
Quarterly Revenue$10.51 B
NVO quarterly revenue is $10.51 billion
Quarterly Gross Profit$8.84 B
NVO quarterly gross profit is $8.84 billion
Quarterly Operating Profit$4.98 B
NVO quarterly operating income is $4.98 billion
Quarterly Net Income$4.02 B
NVO quarterly net profit is $4.02 billion

NVO Quarterly Cost Of Goods Sold Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM Cost Of Goods Sold

$6.04 B
+$248.05 M+4.28%

30 September 2024

1-Year Change

+23.69%
NVO TTM cost of goods sold is up +23.69% year-on-year

3-Year Change

+63.14%
NVO TTM cost of goods sold is up +63.14% over the past 3 years

All-time High

$6.04 B
NVO TTM cost of goods sold is currently at an all-time high

Sector Rank

93.33%
NVO TTM cost of goods sold is higher than 93.33% of companies in Healthcare sector
TTM Revenue$39.36 B
NVO TTM revenue is $39.36 billion
TTM Gross Profit$33.32 B
NVO TTM gross profit is $33.32 billion
TTM Operating Profit$17.23 B
NVO TTM operating income is $17.23 billion
TTM Net Income$13.79 B
NVO TTM net profit is $13.79 billion

NVO TTM Cost Of Goods Sold Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

NVO Cost Of Goods Sold Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+28.8%+17.5%+23.7%
3 y3 years+61.9%+73.5%+63.1%
5 y5 years+86.1%+120.4%+107.0%

NVO Cost Of Goods Sold High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 yearsat high+61.9%at high+91.8%at high+63.1%
5 y5 yearsat high+86.1%at high+136.5%at high+107.0%
alltimeall timeat high+2554.1%at high+440.9%at high+1860.1%

Novo Nordisk A/S Cost Of Goods Sold History

DateAnnualQuarterlyTTM
Sept 2024
-
$1.67 B(+12.4%)
$6.04 B(+4.3%)
June 2024
-
$1.48 B(+2.7%)
$5.79 B(+6.1%)
Mar 2024
-
$1.44 B(-0.1%)
$5.46 B(+5.1%)
Dec 2023
$5.19 B(+28.8%)
$1.45 B(+1.9%)
$5.19 B(+6.3%)
Sept 2023
-
$1.42 B(+23.5%)
$4.88 B(+10.0%)
June 2023
-
$1.15 B(-2.7%)
$4.44 B(+6.7%)
Mar 2023
-
$1.18 B(+3.9%)
$4.16 B(+3.4%)
Dec 2022
$4.03 B(+7.1%)
$1.14 B(+16.5%)
$4.02 B(+4.6%)
Sept 2022
-
$974.76 M(+12.2%)
$3.85 B(+0.4%)
June 2022
-
$868.84 M(-16.7%)
$3.83 B(-0.8%)
Mar 2022
-
$1.04 B(+8.7%)
$3.86 B(+2.7%)
Dec 2021
$3.76 B(+17.4%)
$959.94 M(-0.1%)
$3.76 B(+1.6%)
Sept 2021
-
$960.60 M(+6.9%)
$3.70 B(+4.2%)
June 2021
-
$898.96 M(-4.6%)
$3.55 B(+5.8%)
Mar 2021
-
$942.00 M(+4.7%)
$3.36 B(+4.6%)
Dec 2020
$3.21 B(+6.5%)
$900.09 M(+11.1%)
$3.21 B(+3.0%)
Sept 2020
-
$809.82 M(+14.9%)
$3.11 B(+1.8%)
June 2020
-
$704.73 M(-11.4%)
$3.06 B(-0.8%)
Mar 2020
-
$795.14 M(-1.3%)
$3.09 B(+2.5%)
Dec 2019
$3.01 B(+7.9%)
$805.27 M(+6.5%)
$3.01 B(+3.2%)
Sept 2019
-
$756.01 M(+3.6%)
$2.92 B(+2.4%)
June 2019
-
$729.52 M(+1.3%)
$2.85 B(+1.1%)
Mar 2019
-
$720.17 M(+1.2%)
$2.82 B(+1.0%)
Dec 2018
$2.79 B(+4.0%)
$711.35 M(+3.3%)
$2.79 B(-1.1%)
Sept 2018
-
$688.48 M(-1.3%)
$2.82 B(+0.5%)
June 2018
-
$697.33 M(+0.7%)
$2.81 B(+1.6%)
Mar 2018
-
$692.39 M(-6.9%)
$2.76 B(+3.1%)
Dec 2017
$2.68 B(+5.1%)
$743.69 M(+10.2%)
$2.68 B(+1.2%)
Sept 2017
-
$675.12 M(+3.6%)
$2.65 B(+3.0%)
June 2017
-
$651.92 M(+7.0%)
$2.57 B(+1.5%)
Mar 2017
-
$608.99 M(-14.6%)
$2.53 B(-0.7%)
Dec 2016
$2.55 B(+6.0%)
$713.12 M(+19.3%)
$2.55 B(+1.5%)
Sept 2016
-
$597.69 M(-2.7%)
$2.51 B(+1.0%)
June 2016
-
$614.09 M(-1.9%)
$2.49 B(+1.7%)
Mar 2016
-
$625.99 M(-7.4%)
$2.45 B(+1.6%)
Dec 2015
$2.41 B(-7.3%)
$675.74 M(+18.0%)
$2.41 B(+0.2%)
Sept 2015
-
$572.90 M(+0.3%)
$2.40 B(-1.5%)
June 2015
-
$571.40 M(-2.6%)
$2.44 B(-4.1%)
Mar 2015
-
$586.76 M(-12.6%)
$2.54 B(-1.9%)
Dec 2014
$2.60 B(+3.2%)
$671.05 M(+10.2%)
$2.59 B(+2.0%)
Sept 2014
-
$609.21 M(-9.7%)
$2.54 B(-0.7%)
June 2014
-
$674.61 M(+6.0%)
$2.56 B(+1.7%)
Mar 2014
-
$636.27 M(+2.6%)
$2.51 B(-0.1%)
Dec 2013
$2.52 B(+8.3%)
$620.43 M(-1.0%)
$2.52 B(+3.0%)
Sept 2013
-
$626.44 M(-0.8%)
$2.45 B(+1.7%)
June 2013
-
$631.68 M(-1.1%)
$2.40 B(+1.7%)
Mar 2013
-
$638.68 M(+16.5%)
$2.36 B(+1.7%)
Dec 2012
$2.33 B(-1.1%)
$548.26 M(-6.3%)
$2.32 B(-0.7%)
Sept 2012
-
$585.06 M(-1.0%)
$2.34 B(-1.3%)
June 2012
-
$591.23 M(-1.5%)
$2.37 B(-0.3%)
Mar 2012
-
$600.04 M(+6.1%)
$2.38 B(+1.2%)
DateAnnualQuarterlyTTM
Dec 2011
$2.35 B(+13.1%)
$565.29 M(-8.3%)
$2.35 B(+0.2%)
Sept 2011
-
$616.63 M(+3.1%)
$2.35 B(+4.8%)
June 2011
-
$598.06 M(+4.6%)
$2.24 B(+4.2%)
Mar 2011
-
$571.87 M(+1.8%)
$2.15 B(+3.4%)
Dec 2010
$2.08 B(+6.4%)
$561.76 M(+10.4%)
$2.08 B(+1.9%)
Sept 2010
-
$508.96 M(+0.3%)
$2.04 B(-0.3%)
June 2010
-
$507.22 M(+1.4%)
$2.05 B(+1.5%)
Mar 2010
-
$500.19 M(-4.3%)
$2.02 B(+3.1%)
Dec 2009
$1.95 B(-2.1%)
$522.87 M(+1.4%)
$1.96 B(+3.8%)
Sept 2009
-
$515.76 M(+8.0%)
$1.88 B(-0.5%)
June 2009
-
$477.60 M(+8.7%)
$1.89 B(-2.9%)
Mar 2009
-
$439.51 M(-2.8%)
$1.95 B(-2.3%)
Dec 2008
$2.00 B(+10.7%)
$451.95 M(-13.8%)
$2.00 B(-2.7%)
Sept 2008
-
$524.42 M(-2.0%)
$2.05 B(+3.0%)
June 2008
-
$535.14 M(+10.3%)
$1.99 B(+5.7%)
Mar 2008
-
$485.04 M(-4.4%)
$1.88 B(+4.3%)
Dec 2007
$1.80 B(+11.6%)
$507.39 M(+9.3%)
$1.81 B(+3.5%)
Sept 2007
-
$464.01 M(+8.7%)
$1.75 B(+3.8%)
June 2007
-
$427.00 M(+4.6%)
$1.68 B(+2.9%)
Mar 2007
-
$408.19 M(-8.7%)
$1.64 B(+1.2%)
Dec 2006
$1.61 B(+5.5%)
$447.10 M(+11.8%)
$1.62 B(+2.9%)
Sept 2006
-
$399.83 M(+5.2%)
$1.57 B(+0.9%)
June 2006
-
$379.90 M(-2.3%)
$1.56 B(+0.5%)
Mar 2006
-
$388.99 M(-3.0%)
$1.55 B(+1.4%)
Dec 2005
$1.53 B(+12.9%)
$400.99 M(+4.0%)
$1.53 B(+0.8%)
Sept 2005
-
$385.61 M(+3.5%)
$1.51 B(+2.9%)
June 2005
-
$372.54 M(+1.3%)
$1.47 B(+4.1%)
Mar 2005
-
$367.74 M(-5.4%)
$1.41 B(+4.4%)
Dec 2004
$1.36 B(+19.3%)
$388.75 M(+13.2%)
$1.36 B(+40.2%)
Sept 2004
-
$343.54 M(+9.1%)
$966.48 M(+55.1%)
June 2004
-
$314.84 M(+2.2%)
$622.93 M(+102.2%)
Mar 2004
-
$308.10 M
$308.10 M
Dec 2003
$1.14 B(+34.7%)
-
-
Dec 2002
$843.01 M(+17.6%)
-
-
Dec 2001
$716.87 M(+32.1%)
-
-
Dec 2000
$542.84 M(+4.3%)
-
-
Dec 1999
$520.59 M(+8.3%)
-
-
Dec 1998
$480.73 M(-32.9%)
-
-
Dec 1997
$716.10 M(-0.4%)
-
-
Dec 1996
$718.84 M(+5.1%)
-
-
Dec 1995
$684.04 M(+13.2%)
-
-
Dec 1994
$604.16 M(-38.9%)
-
-
Dec 1993
$989.58 M(+135.9%)
-
-
Dec 1992
$419.49 M(-44.2%)
-
-
Dec 1991
$751.70 M(+12.5%)
-
-
Dec 1990
$668.26 M(+29.5%)
-
-
Dec 1989
$515.83 M(+27.5%)
-
-
Dec 1988
$404.45 M(+6.7%)
-
-
Dec 1987
$379.03 M(-7.2%)
-
-
Dec 1986
$408.28 M(+107.0%)
-
-
Dec 1985
$197.23 M(+0.8%)
-
-
Dec 1984
$195.64 M
-
-

FAQ

  • What is Novo Nordisk A/S annual cost of goods sold?
  • What is the all time high annual cost of goods sold for Novo Nordisk A/S?
  • What is Novo Nordisk A/S annual cost of goods sold year-on-year change?
  • What is Novo Nordisk A/S quarterly cost of goods sold?
  • What is the all time high quarterly cost of goods sold for Novo Nordisk A/S?
  • What is Novo Nordisk A/S quarterly cost of goods sold year-on-year change?
  • What is Novo Nordisk A/S TTM cost of goods sold?
  • What is the all time high TTM cost of goods sold for Novo Nordisk A/S?
  • What is Novo Nordisk A/S TTM cost of goods sold year-on-year change?

What is Novo Nordisk A/S annual cost of goods sold?

The current annual cost of goods sold of NVO is $5.19 B

What is the all time high annual cost of goods sold for Novo Nordisk A/S?

Novo Nordisk A/S all-time high annual cost of goods sold is $5.19 B

What is Novo Nordisk A/S annual cost of goods sold year-on-year change?

Over the past year, NVO annual cost of goods sold has changed by +$1.16 B (+28.76%)

What is Novo Nordisk A/S quarterly cost of goods sold?

The current quarterly cost of goods sold of NVO is $1.67 B

What is the all time high quarterly cost of goods sold for Novo Nordisk A/S?

Novo Nordisk A/S all-time high quarterly cost of goods sold is $1.67 B

What is Novo Nordisk A/S quarterly cost of goods sold year-on-year change?

Over the past year, NVO quarterly cost of goods sold has changed by +$248.05 M (+17.49%)

What is Novo Nordisk A/S TTM cost of goods sold?

The current TTM cost of goods sold of NVO is $6.04 B

What is the all time high TTM cost of goods sold for Novo Nordisk A/S?

Novo Nordisk A/S all-time high TTM cost of goods sold is $6.04 B

What is Novo Nordisk A/S TTM cost of goods sold year-on-year change?

Over the past year, NVO TTM cost of goods sold has changed by +$1.16 B (+23.69%)